Physician profile
Daniel B Morilla
NPI 1932341377
$35,290.60
in general payments reported to CMS, 2019-2025
37 companies · $942 in 2025
The $942 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,487 · 2020: $239 · 2021: $8,897 · 2022: $5,008 · 2023: $18K · 2024: $1,013 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $3,654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,005.20 |
| Food and Beverage | $3,654.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $29,350.00 | 2021-2023 | Da Vinci Surgical System |
| Coloplast Corp | $882.62 | 2019-2025 | Altis |
| Axonics, INC. | $699.85 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $622.00 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml, General - Erectile Dysfunction |
| Abbvie INC. | $607.57 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $526.35 | 2023-2025 | Gemtesa |
| Calyxo, INC. | $215.31 | 2023-2025 | Cvac Aspiration System |
| Ge Healthcare | $186.03 | 2024 | |
| Astellas Pharma US INC | $182.54 | 2019-2023 | Myrbetriq |
| Procept Biorobotics Corporation | $167.51 | 2022-2023 | Aquabeam Robotic System |
| Merck Sharp & Dohme LLC | $166.16 | 2022-2025 | Keytruda, Lynparza |
| Myriad Genetic Laboratories, INC. | $145.19 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $139.59 | 2022-2023 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $130.92 | 2019-2023 | |
| Urogen Pharma, INC. | $130.13 | 2023-2025 | Jelmyto |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $125.00 | 2022 | |
| 180 Medical, INC. | $106.05 | 2019-2025 | Cure Catheter, Self Cath |
| Janssen Biotech, INC. | $99.34 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $98.48 | 2019-2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $95.52 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $87.17 | 2023 | Lynparza |
| Ambu INC. | $79.62 | 2024 | |
| Allergan, INC. | $58.62 | 2019-2021 | |
| Caldera Medical, INC | $50.71 | 2023 | Desara |
| Profound Medical Corp. | $50.18 | 2022 | |
| Agiliti Surgical, INC. | $40.55 | 2019-2020 | |
| Medtronic, INC. | $36.64 | 2024-2025 | Altaviva, Interstim |
| Blue Earth Diagnostics | $26.85 | 2023 | |
| Telix Pharmaceuticals | $25.81 | 2023 | Illuccix |
| Cycle Pharmaceuticals INC | $24.40 | 2025 | Venxxiva |
| Abc Home Medical Supply, INC. | $23.71 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.47 | 2024 | Exparel |
| Urovant Sciences INC | $21.53 | 2022 | |
| Genzyme Corporation | $18.33 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $17.66 | 2022 | |
| Tolmar, INC. | $15.46 | 2023 | |
| Rgh Enterprises LLC | $14.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Morilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.